ArticleScientific reports2025
Differential impact of maternal and paternal metabolic syndrome on offspring's cardiometabolic risk factors.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Parental metabolic syndrome (MetS) is associated with increased cardiometabolic risk in offspring, yet the distinct impacts of maternal versus paternal MetS remain poorly understood. Evidence on sex-specific susceptibility during adolescence is particularly limited, despite this being a critical period for the development of chronic metabolic conditions. Using a comprehensive dataset of 5,245 patients selected from a nationally representative database, we examined the differential association of maternal and paternal MetS with cardiometabolic outcomes in adolescent offspring and their variation by offspring sex. Overall, paternal MetS was associated with higher triglyceride and lower HDL cholesterol in male offspring. In contrast, maternal MetS was linked to higher triglyceride levels in both sexes, with additional associations with elevated systolic blood pressure and lower HDL cholesterol only in males. The odds of MetS and its components were most elevated in male adolescents in both paternal and maternal MetS. In conclusion, paternal MetS appeared to exert a stronger influence, particularly in male adolescents. Our findings suggest that both parental and offspring sexes modify the intergenerational transmission of metabolic risk; it is crucial to consider both parental and offspring sexes for effective screening and the prevention of MetS.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.